Pharma & Biotech

All eyes are on KORU Medical Systems as the medical technology firm prepares to release its third-quarter 2025 financial results...

The upcoming quarterly report from Heron Therapeutics represents a pivotal moment for the biotechnology firm's stock performance. Scheduled for release...

Investors are closely watching Mirum Pharmaceuticals as the biopharmaceutical company prepares to release its third-quarter 2025 financial results this Tuesday....

Investors in Catalyst Pharmaceuticals are bracing for a significant market-moving event this week as the biopharma company prepares to release...

This week represents a critical juncture for Altimmune as the biopharmaceutical company prepares to release its third-quarter 2025 financial results...

The German biotech firm CureVac has delivered a remarkable financial performance that has captivated both investors and market analysts. After...

BioNxt Solutions, a Canadian life sciences company, has reached a significant regulatory milestone that could strengthen its intellectual property portfolio....

Biotechnology firm Ocugen stands at a pivotal juncture as it prepares to release third-quarter financial results on Wednesday, November 5....

Investors in Viking Therapeutics were met with sobering financial results for the third quarter of 2025, as the biotechnology firm...

Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market forecasts when it released quarterly results...